MiR-145 and SMAD3 expression in patients with cystic fibrosis

F. Megiorni, S. Cialfi, G. Cimino, R. V. De Biase, D. Savi, C. Dominici, A. Pizzuti, S. Quattrucci (Rome, Italy)

Source: Annual Congress 2013 –Cystic fibrosis: basic and applied science
Session: Cystic fibrosis: basic and applied science
Session type: Poster Discussion
Number: 2105
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 5
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
F. Megiorni, S. Cialfi, G. Cimino, R. V. De Biase, D. Savi, C. Dominici, A. Pizzuti, S. Quattrucci (Rome, Italy). MiR-145 and SMAD3 expression in patients with cystic fibrosis. Eur Respir J 2013; 42: Suppl. 57, 2105

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

Paul Bongaerts (Echt, Netherlands) - 07.09.2013 13:25
A difficult subject. It is very good that there is attention for this subject.

Wim Put (Vroenhoven, Belgium) - 07.09.2013 13:21
great
You must Login to comment this presentation.


Related content which might interest you:
Mitophagic regulation of myofibroblast differentiation in lung fibroblasts
Source: International Congress 2014 – Novel approaches in transcriptomics and epigenomics in inflammatory lung diseases and lung cancer
Year: 2014


Immunoproteasome expression in pulmonary fibrosis
Source: Annual Congress 2013 –Cell signalling and inflammation: what's new in 2013?
Year: 2013

MiR-31 regulates IRF-1 function in cystic fibrosis epithelial cells
Source: International Congress 2014 – Novel epigenetic regulators for targeting via nanomedicine
Year: 2014

Molecular mechanisms of pirfenidone activity in human lung fibroblasts
Source: International Congress 2014 – Basic and translational research in lung cancer and non-neoplastic pulmonary diseases
Year: 2014


The role of Foxc2 gene in lung development
Source: International Congress 2014 – Basic and translational research in lung cancer and non-neoplastic pulmonary diseases
Year: 2014


A role of Foxc2 gene in mice with bleomycin-induced pulmonary fibrosis
Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease
Year: 2015


Mitochondrial tRNA gene mutations in patients with idiopathic pulmonary fibrosis (IPF) and sarcoidosis
Source: International Congress 2014 – Basic and translational research in lung cancer and non-neoplastic pulmonary diseases
Year: 2014

KCa3.1 mediates alphaSMA expression in human lung myofibroblast via the Smad2/3 and TGFbeta1 signalling pathway
Source: International Congress 2014 – Cell biology 2014
Year: 2014

Regulation of interleukin-8 by miR-17 during chronic inflammation in cystic fibrosis
Source: International Congress 2015 – The multiple faces of host defense
Year: 2015



The role of miR-21 and miR-34a in the fibrotic process of the lung
Source: International Congress 2016 – IPF pathogenesis
Year: 2016

Mesenchyme associated transcription factor PRRX1: A key regulator of IPF fibroblast
Source: International Congress 2016 – Repair pathways: from lung development to ageing of the lung
Year: 2016

Metformin inhibits TGF-b-induced myofibroblast differentiation through AMPK activation
Source: International Congress 2014 – Cell biology 2014
Year: 2014

Loss of CARM1 prolongs bleomycin-induced pulmonary fibrosis
Source: International Congress 2014 – Animal models: asthma, COPD and beyond
Year: 2014

Increased levels of glycosaminoglycans in lungs from patients with IPF
Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease
Year: 2015

ATF3 regulates PINK1 transcription in lung epithelial cells of the aging lung
Source: International Congress 2016 – Repair pathways: from lung development to ageing of the lung
Year: 2016

Polymorphisms in NOS-1 and NOS-3 genes may influence the cystic fibrosis severity?
Source: International Congress 2014 – Cystic fibrosis: genotypes, inflammation and microbiology
Year: 2014

Role of MUC1 in idiopathic pulmonary fibrosis
Source: International Congress 2016 – ILD pathogenesis
Year: 2016

Novel protein biomarkers of bronchiectasis in children with cystic fibrosis
Source: International Congress 2014 – Cystic fibrosis: basic science, physiology and clinical aspects
Year: 2014

MiR-320c regulates SERPINA1 expression and is associated with pulmonary disease in alpha-1-antitrypsin deficiency
Source: International Congress 2016 – How the understanding og molecular and genomic crosstalk is helping to diagnose lung disease
Year: 2016

Genetic characterization of cystic fibrosis patients in Portugal
Source: Annual Congress 2013 –Cystic fibrosis: clinical problems, genetics and microbiology in children
Year: 2013